LFST:NSD-Lifestance Health Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 7.29

Change

+0.03 (+0.41)%

Market Cap

USD 2.74B

Volume

0.38M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

+0.87 (+0.65%)

USD 8.25B
OPCH Option Care Health Inc

-0.11 (-0.48%)

USD 4.00B
ACHC Acadia Healthcare Company Inc

+0.17 (+0.45%)

USD 3.78B
AMED Amedisys Inc

+0.08 (+0.09%)

USD 2.81B
SGRY Surgery Partners Inc

-0.09 (-0.43%)

USD 2.59B
ADUS Addus HomeCare Corporation

+0.03 (+0.02%)

USD 2.27B
ASTH Astrana Health Inc

+0.01 (+0.03%)

USD 1.89B
AVAH Aveanna Healthcare Holdings In..

-0.06 (-1.34%)

USD 1.04B
HCSG Healthcare Services Group Inc

+0.39 (+3.51%)

USD 0.91B
CCRN Cross Country Healthcare Inc

+0.07 (+0.39%)

USD 0.58B

ETFs Containing LFST

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.90% 67% D+ 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.90% 67% D+ 40% F
Trailing 12 Months  
Capital Gain -6.90% 67% D+ 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.90% 67% D+ 40% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -8.71% 48% F 22% F
Dividend Return -8.71% 48% F 22% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 31.08% 70% C- 61% D-
Risk Adjusted Return -28.03% 37% F 20% F
Market Capitalization 2.74B 84% B 82% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector